4.1 Article

IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2-ERK1/2 Pathway

Xi-Xiang Yu et al.

DIGESTIVE DISEASES AND SCIENCES (2015)

Article Medicine, Research & Experimental

IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms

Lukas F. Mager et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Oncology

Serum IL-33 as a Diagnostic and Prognostic Marker in Nonsmall Cell Lung Cancer

Liang-An Hu et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)

Meeting Abstract Gastroenterology & Hepatology

HIGH SERUM LEVELS OF THE INTERLEUKIN 33 RECEPTOR SOLUBLE ST2 AS A NEGATIVE PROGNOSTIC FACTOR IN HEPATOCELLULAR CARCINOMA

D. Bergis et al.

JOURNAL OF HEPATOLOGY (2013)

Editorial Material Oncology

IL-33/ST2 axis in innate and acquired immunity to tumors

Ivan P. Jovanovic et al.

ONCOIMMUNOLOGY (2012)

Article Immunology

ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma

Ivan Jovanovic et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2011)

Review Urology & Nephrology

Basic Research in Kidney Cancer

Egbert Oosterwijk et al.

EUROPEAN UROLOGY (2011)

Review Urology & Nephrology

Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review

Maxine Sun et al.

EUROPEAN UROLOGY (2011)

Review Urology & Nephrology

The Epidemiology of Renal Cell Carcinoma

Borje Ljungberg et al.

EUROPEAN UROLOGY (2011)

Review Immunology

Role of IL-33 in inflammation and disease

Ashley M. Miller

JOURNAL OF INFLAMMATION-LONDON (2011)

Editorial Material Oncology

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

Stephen B. Edge et al.

ANNALS OF SURGICAL ONCOLOGY (2010)

Review Biotechnology & Applied Microbiology

The IL-33/ST2 pathway: therapeutic target and novel biomarker

Rahul Kakkar et al.

NATURE REVIEWS DRUG DISCOVERY (2008)

Review Multidisciplinary Sciences

Nuclear factor-κB in cancer development and progression

Michael Karin

NATURE (2006)